Keyphrases
Pioglitazone
100%
Adult Patients
100%
Type 2 Diabetic Patients
100%
Weight Gain Prevention
100%
Weight Gain
66%
Type 2 Diabetes Mellitus (T2DM)
33%
Treatment Programs
33%
Lifestyle Treatment
33%
Abdominal Adipose Tissue
33%
Prospective Randomized Trial
16%
Lifestyle Intervention
16%
Body Composition
16%
Three-level
16%
Weight Change
16%
Beneficial Effects
16%
Dose-response
16%
Computed Tomography
16%
Total Body Fat
16%
Between-group
16%
Dual-energy X-ray Absorptiometry
16%
Subcutaneous Fat
16%
Obese Subjects
16%
Thiazolidinediones
16%
Weight Management Program
16%
Overweight Subjects
16%
Total Body Water
16%
Changes in Body Weight
16%
Intensive Lifestyle
16%
Lifestyle Clusters
16%
Multifrequency Bioimpedance Analysis
16%
Response Effectiveness
16%
Nursing and Health Professions
Patient with Type 2 Diabetes
100%
Pioglitazone
100%
Non Insulin Dependent Diabetes Mellitus
33%
Dual Energy X Ray Absorptiometry
16%
Body Composition
16%
Body Weight
16%
Obesity
16%
Body Fat
16%
Body Weight Change
16%
Computer Assisted Tomography
16%
Weight Management
16%
Thiazolidinedione
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pioglitazone
100%
Non Insulin Dependent Diabetes Mellitus
100%
Obesity
16%
Thiazolidinedione
16%